Dr. Johann Hecht’s practice includes international corporate and capital markets transactions, including domestic and cross-border mergers and acquisitions, including regulatory advice and compliance.

Dr. Hecht joined Skadden in April 2016 from another major international law firm and has since advised on significant transactions, including:

  • MorphoSys AG in its U.S. IPO and dual listing of American depositary shares on Nasdaq;
  • J.P. Morgan and UBS as joint bookrunners in connection with a capital increase and a global private placement of the new shares by TLG IMMOBILIEN AG;
  • Goldman Sachs International and Deutsche Bank as joint global coordinators in connection with the contemplated IPO of OFFICEFIRST Immobilien AG, a spin-off of the core portfolio of IVG Immobilien AG;
  • SGL Carbon SE in connection with its 2016 capital increase;
  • the Austrian Province of Carinthia, Kaerntner Landesholding (KLH) and Kaerntner Ausgleichszahlungs-Fonds (K-AF), a special purpose vehicle set up by the Province of Carinthia, in connection with the debt restructuring of HETA Asset Resolution AG, the wind-down entity of the former Austrian Bank Hypo Alpe Adria, and the issuance of Secured Zero Coupon Bonds in an amount of €10.3 billion;
  • AGRAVIS Raiffeisen AG in connection with issuance of hybrid capital;
  • Merck KGaA in its US$17 billion acquisition of Sigma-Aldrich Corporation, a chemical company for the life science industry; and
  • a German vehicle manufacturer with the provision of advice regarding ongoing U.S. and related investigations of emission control devices.



  • Dr. jur., University of Bayreuth, 2012
  • Second State Exam, Higher Regional Court Hamburg, 2014
  • First State Exam, University of Bayreuth, 2009


  • Frankfurt

Johann Hecht